NEOMYCIN SULFATE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Neomycin Sulfate, and what generic alternatives are available?
Neomycin Sulfate is a drug marketed by Adrastea Pharma, Bristol Myers Squibb, Chartwell Molecular, Lannett, Lilly, Nostrum Labs Inc, Roxane, Sandoz, Teva, Bausch And Lomb, Pharmafair, Alcon Pharms Ltd, Fougera, and Pharmaderm. and is included in twenty NDAs.
The generic ingredient in NEOMYCIN SULFATE is neomycin sulfate; triamcinolone acetonide. There are nineteen drug master file entries for this compound. Additional details are available on the neomycin sulfate; triamcinolone acetonide profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for NEOMYCIN SULFATE?
- What are the global sales for NEOMYCIN SULFATE?
- What is Average Wholesale Price for NEOMYCIN SULFATE?
Summary for NEOMYCIN SULFATE
| US Patents: | 0 |
| Applicants: | 14 |
| NDAs: | 20 |
| Finished Product Suppliers / Packagers: | 4 |
| Raw Ingredient (Bulk) Api Vendors: | 99 |
| Clinical Trials: | 11 |
| Patent Applications: | 3,991 |
| DailyMed Link: | NEOMYCIN SULFATE at DailyMed |
Recent Clinical Trials for NEOMYCIN SULFATE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Vietstar Biomedical Research | N/A |
| Huro Biotech Joint Stock Company | N/A |
| Mahidol University | Phase 4 |
Pharmacology for NEOMYCIN SULFATE
| Drug Class | Aminoglycoside Antibacterial |
Medical Subject Heading (MeSH) Categories for NEOMYCIN SULFATE
Anatomical Therapeutic Chemical (ATC) Classes for NEOMYCIN SULFATE
US Patents and Regulatory Information for NEOMYCIN SULFATE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Adrastea Pharma | NEOMYCIN SULFATE | neomycin sulfate | TABLET;ORAL | 065220-001 | Jul 28, 2006 | AA | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Fougera | NEOMYCIN SULFATE-TRIAMCINOLONE ACETONIDE | neomycin sulfate; triamcinolone acetonide | OINTMENT;TOPICAL | 062608-001 | May 23, 1986 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Roxane | NEOMYCIN SULFATE | neomycin sulfate | TABLET;ORAL | 062173-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Lannett | NEOMYCIN SULFATE | neomycin sulfate | TABLET;ORAL | 060607-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Alcon Pharms Ltd | NEOMYCIN SULFATE-DEXAMETHASONE SODIUM PHOSPHATE | dexamethasone sodium phosphate; neomycin sulfate | SOLUTION/DROPS;OPHTHALMIC | 062714-001 | Jul 21, 1986 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
